Refractory multiple myeloma treated with homoharringtonine: report of two cases

被引：7

作者：

Yang, Xiudi

Yang, Chunmei

Shao, Keding

Ye, Xingnong

Meng, Haitao

Zhou, Yuhong

Qian, Wenbin

机构：

[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Peoples R China

[2] Zhejiang Hosp Tradit Chinese Med, Dept Hematol, Hangzhou 310006, Peoples R China

来源：

ANNALS OF HEMATOLOGY | 2007年 / 86卷 / 12期

关键词：

D O I：

10.1007/s00277-007-0331-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：919 / 921

页数：3

共 5 条

[1]

Feldman EJ, 1996, LEUKEMIA, V10, P40

[2] Molecular mechanisms of novel therapeutic approaches for multiple myeloma [J].

Hideshima, T ;

Anderson, KC .

NATURE REVIEWS CANCER, 2002, 2 (12) :927-937

[3] Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia [J].

Jin, J. ;

Jiang, D-Z ;

Mai, W-Y ;

Meng, H-T ;

Qian, W-B ;

Tong, H-Y ;

Huang, J. ;

Mao, L-P ;

Tong, Y. ;

Wang, L. ;

Chen, Z. M. ;

Xu, W-L .

LEUKEMIA, 2006, 20 (08) :1361-1367

[4]

Luo Chang Ying, 2004, Hematology, V9, P259, DOI 10.1080/10245330410001714194

[5] HOMOHARRINGTONINE THERAPY INDUCES RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN LATE CHRONIC PHASE [J].

OBRIEN, S ;

KANTARJIAN, H ;

KEATING, M ;

BERAN, M ;

KOLLER, C ;

ROBERTSON, LE ;

HESTER, J ;

RIOS, M ;

ANDREEFF, M ;

TALPAZ, M .

BLOOD, 1995, 86 (09) :3322-3326

← 1 →